Statins use and risk for brain metastasis from lung cancer

D. Leigh, J. Eken, J. R. Beal, A. K. Ganti, A. E. Sahmoun

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


Laboratory data suggest an association between statins and risk of brain metastasis (BM) in patients diagnosed with lung cancer. Our retrospective cohort included 252 patients diagnosed with lung cancer and 55 (22) patients subsequently developed BM. The risk of BM was significantly higher in younger patients (p < .0007). The multivariable Cox model did not show a significant association between statin use and BM from lung cancer (Hazard-Ratio (HR) 1.20, 95 confidence interval (CI): 0.682.13). Future studies should focus on late stage NSCLC and examine the incidence of BM among statin users at the time of death.

Original languageEnglish (US)
Pages (from-to)68-72
Number of pages5
JournalCancer Investigation
Issue number1
StatePublished - Jan 2011


  • Brain metastasis
  • Cohort
  • Epidemiology
  • Hydrophobic
  • Lung cancer
  • Statins

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Statins use and risk for brain metastasis from lung cancer'. Together they form a unique fingerprint.

Cite this